Our goal is to identify and uncover important molecular mechanisms of coagulation proteins contributing to or preventing disease, that can be utilized in the treatment of patients. We also manage a general biobank containing biological samples from patients with different types of haemostatic or thrombotic disorders, for use in research.
Our main projects are:
- Cell therapy in inherited FVII deficiency
- Liver-like organoids to study AT mutation
- Bone marrow microenvironment in multiple myeloma
- Coagulation proteins in atherosclerotic disease
- Laboratory analyses in clinical studies
Financial support and collaboration
Our research is funded by the Oslo University Hospital (OUS), Fondsstiftelsen, the South-Eastern Norway Regional Health Authority (HSØ), the Research Council of Norway, and Bløderfondet. We have several central collaborators both nationally and internationally in addition to cooperating with other research groups and clinical personnel at the RIIM and OUS.